Page last updated: 2024-12-08

ketopinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ketopinic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID297888
CHEMBL ID2165571
SCHEMBL ID2735035
MeSH IDM0394843

Synonyms (31)

Synonym
EU-0075506
6994-94-1
nsc-169208
nsc169208
CHEMDIV2_000707
OPREA1_690247
AKOS000267801
HMS1371A03
FT-0658239
FT-0690244
K0028
ketopinic acid
464-78-8
(+)-ketopic acid
(1s)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid
7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxylic acid
STL227741
bicyclo[2.2.1]heptane-1-carboxylicacid, 7,7-dimethyl-2-oxo-
CHEMBL2165571
AKOS016039177
SCHEMBL2735035
bicyclo[2.2.1]heptane-1-carboxylic acid, 7,7-dimethyl-2-oxo-
1-norbornanecarboxylic acid, 7,7-dimethyl-2-oxo-
bicyclo[2.2.1]heptane-1-carboxylicacid,7,7-dimethyl-2-oxo-
DTXSID70990207
AMY13868
A872256
AS-78558
CS-0200303
EN300-54947
Z818939916
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.33 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]